Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Cameron R Wolfe,Kay M Tomashek,Thomas F Patterson,Carlos A Gomez,Vincent C Marconi,Mamta K Jain,Otto O Yang,Catharine I Paules,Guillermo M Ruiz Palacios,Robert Grossberg,Michelle S Harkins,Richard A Mularski,Nathaniel Erdmann,Uriel Sandkovsky,Eyad Almasri,Justino Regalado Pineda, Alexandra W Dretler,Diego Lopez de Castilla,Angela R Branche,Pauline K Park,Aneesh K Mehta,William R Short,Susan L F McLellan,Susan Kline,Nicole M Iovine,Hana M El Sahly,Sarah B Doernberg,Myoung-Don Oh,Nikhil Huprikar,Elizabeth Hohmann,Colleen F Kelley,Mark Holodniy,Eu Suk Kim,Daniel A Sweeney,Robert W Finberg,Kevin A Grimes,Ryan C Maves,Emily R Ko,John J Engemann,Barbara S Taylor,Philip O Ponce,LuAnn Larson,Dante Paolo Melendez,Allan M Seibert,Nadine G Rouphael,Joslyn Strebe,Jesse L Clark,Kathleen G Julian,Alfredo Ponce de Leon,Anabela Cardoso,Stephanie de Bono,Robert L Atmar,Anuradha Ganesan,Jennifer L Ferreira,Michelle Green,Mat Makowski,Tyler Bonnett,Tatiana Beresnev,Varduhi Ghazaryan,Walla Dempsey,Seema U Nayak,Lori E Dodd,John H Beigel,Andre C Kalil The Lancet Respiratory Medicine(2022)
摘要
National Institute of Allergy and Infectious Diseases.
更多查看译文
AI 理解论文
溯源树
样例